Ketanji Brown Jackson Goes Rogue With Flurry Of Solo Supreme Court Dissents
Justice Ketanji Brown Jackson has written multiple lone dissents this term, clashing with the Court on voting maps, nationwide injunctions and NIH funding. Her solo opinions press a consistent critique of procedure and remedies.
Tar Heel Power Play as David Price Joins Ex-Officials in War Powers Showdown
Former Rep. David Price joined 62 ex-officials in a letter urging Congress to reclaim war-making authority as the Iran conflict passed the War Powers deadline.
K Street Cringes At Sean Duffy’s Sponsor-Fueled Family Road Trip Show
Transportation Secretary Sean Duffy’s family stars in a new reality series funded by a nonprofit whose sponsor page lists companies the DOT regulates. Critics and ethics experts say the arrangement raises troubling optics.
Trump's Beijing Visit Ignites Hope For Jailed Uyghur Tech Founder
President Trump’s May 14–15 Beijing trip has renewed hope for Rayhan Asat, whose brother Ekpar has been detained in Xinjiang since 2016. Advocates want his case raised directly with Xi.
D.C. Doctors Sound Alarm, Urge Rapid Move To Remove Trump From Office
Thirty-six medical experts told the Senate they believe President Trump is mentally unfit and urged urgent removal, citing worsening cognition and national‑security risks. Their statement was printed in the Congressional Record.
DC Slaps Sanctions on Chinese Satellite Trio Tied to Iran Strikes on U.S. Forces
Washington sanctioned three Chinese satellite firms accused of supplying imagery that helped Iran target U.S. forces, widening a sanctions push ahead of a key China summit.
Fed Puts Wall Street On Edge As Oil Shock, War Fears Top Risk List
The Fed’s Financial Stability Report names geopolitical turmoil and an oil‑price shock as the top near‑term risks to markets, with AI‑funded debt and private credit adding fragility.
D.C. Vape Crackdown Blinks As FDA Gives Some Makers A Temporary Pass
The FDA's May 8 guidance says some e‑cigarettes and nicotine pouches with accepted applications won't be a priority for enforcement while reviews continue. The change could keep certain products on shelves during scientific review.












